Oxaliplatin and irinotecan

TERMINATED · PHASE2 · Colon Tumors, Rectum Tumors, Appendix Tumors, Peritoneum Tumors, Endocrine Tumors

Unknown stopping reason

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.